​Job Description / Capsule

An internal and externally facing medical role that provides medical and clinical expertise in priority therapeutic/diseaseareasandbuildsAZscientificleadership.Participatesandcontributeswith medical andclinicalexpertiseindesignofLCM and Brand Strategy. Takesleadership in implementation ofMedical Plan/ activities in alignment with Brandstrategy.Ensuresthat the Medical Activities meet the needs of patients and customers.Engages Opinion Leaders in ESRs, scientific exchange meetings and advisory board meetings. Defines and delivers training on Medical background of the product or various functionsinan organization.Maytakeresponsibilityas NominatedSignatorymedicalreviewer for activitiesand promotional

materials.MaytakeresponsibilityformentorshipofMSL/sinthecountry.MayleadMedicalInformationand

Pharmacovigilancewithinaparticularmarket.

Objectives

1/To establish AstraZeneca as a scientific leader through proactive,updatedandeffective Medical input

Criticalactions

• Continuouslyacquireandupdatenecessary scientific knowledge on therapeutic area and relevant compounds.
• Develop and implement the local medical plan to address unmet medical needs in prioritydiseaseareasandensurealignment with the brand plan.
• CollaboratewithMSLtoseekinputfrom MSL insights for development of local medical plan .
• Developandimplementpre-launchmedical plan/activities for new products at least 2 years prior to the planned launch in the countrytoaddresskeyclinicalandscientific challenges
• Provide medical leadership on faculty and content development for medical programmesincludingnationalcongresses, advisory boards, scientific exchange meetings, publications, CMEs to meet identified needs
• To ensure that the Medical Information provided both to external and internal customersistimely,relevant,accurateand scientifically balanced
• Providelocalmedicalexpertisetolocal area/regional brand teams
• Providemedicalinputtophase1to4 study protocols, study feasibility and support operational delivery
• ProvideMedicalexpertisetosupportPSP market research, PASS and ESRO

Measures(Quantitative–Qualitative–Attitudinal)

Quantity

• Completionofthemedical academy
• NumberofreactiveESRO discussion
• Delivery of approved prelaunch medicalplanincooperatewithlocal brand strategy
• Implementationoftheprelaunch medical plan.

Quality

• Proactive update of medical knowledgeintheinternalmeeting
• AnapprovedMedicalplanthatis fullyalignedwiththeBrandplan.
• Medical information should meet definedmarketsstandards–time, quality in 5 days.

2/ To engagescientific leaders, professionalbodiesorsocieties to establish AZ as a scientific leader

Criticalactions

• 40% of time in field is required for engagement with the highest priority HCPs andkeyexternalstakeholdersengagement
• ShareemergingdatawithHCPs,discussing all aspects of the data in a scientific, objective and balanced way
• Disseminateresultsofstudiescompletedto medical community by translating their clinical values and incorporating into business strategies
• Attend relevant scientific congresses and HCPmeetingstogathernewknowledgeon AZ compounds,competitor information and therapeutic area
• Conduct professional scientific communicationorpresentation(become chairperson/presenter when necessary) with key opinion leaders (prominent
• Liaise with local investigators and the ExternalSponsoredResearchorganization to support research initiatives.
• Internallycommunicatecompetitive intelligence

Measures(Quantitative–Qualitative–Attitudinal)

Quantity

• Timeinfieldversusplan
• Timeliness and actual number of achievements:P2P,1:1interaction, advisory board, publication, CME, responses to queries versus plan
• Market preparation of new launch productand/orpipelineamongOLs.

Quality

• Customerfeedbackpost events/symposia

3/Generatethemedicalevidence tosupportthebrandstrategies in priority TAs to meet unmet medical needs

Criticalactions

• Ideagenerationofthecompanysponsored clinical research
• Oversightandaccountabilityofthe operation of the studies
• Initiate research discussions, for example NIS,withcustomerstodevelopstudiesthat will fulfil global and local business strategies. (May aspart of thereview team conduct initial assessment of any ISS proposals)Participate as key member of brand team as strategic partner towards LCM actions including potential business development opportunities
• DevelopNISorregistrystudiestoaddress unmet medical needs.
• DevelopingpartnershipwithOLsinorderto develop their capabilities of conducting medical studies

Measures(Quantitative–Qualitative–Attitudinal)

• Numberofdiscussion-NIS/IIS Proposals
• Oversight the all accountability of the operation of the studies, i.e. Milestones,qualityandcapacityof the study
• Timelypublicationsofstudies completed
• Initiatives with investigatorsto developcapabilitiesinconducting medical studies

4/Provide medical expertise to shaperegulatoryenvironmentto achieve rapid and high quality market access of AZ products including new registration, new product evaluation and life cycle

Criticalactions

• Supporttodevelopdrugvaluepackand communicateittoKeyDecisionMakers
• Supportmarketaccessactivitiesthatshape marketunderstandingofdisease,diagnosis andtreatment options
• Proactivecrossfuctionalcollaborationwith regulatory and other teams in drug registration in earlier and broader accessibility aligned to the brand strategy

Measures(Quantitative–Qualitative–Attitudinal)

Quantity

• NumberofcommunicationstoKDMs versus plan
• Meetthecriticalproject timeline

Quality

• Feedbackfromcrossfunctionalteam

5/ Definesanddeliverstrainingon Medical background of the productforvariousfunctionsin an organization as required

Criticalactions

• Provide effective Medical/clinical trainings (basicscienceanddiseaseknowledge,drug profile, clinical data) to internal colleagues in line with expressed needs of MSL manager and sales managers:
• Ensuresownknowledgeandknowledgeof team members of best practices and new relevant developments is up to date

Measures(Quantitative–Qualitative–Attitudinal)

Quantity

• Percent completion of trainings conductedversusplanasperthe business needs versus plan

Quality

• Feedback from participants ; facilitatoreffectivenessaverage more than 4 points
• MSLandMRcompetencyintermsof disease knowledge, drug profile and clinical data (through MSLAccreditation)

6/ Governanceandensuringoverall adherence to processes and regulation [include but not limit to patient safety, clinical trials, promotional activities, etc …]

Criticalactions

• Accountable for ensuring Promotional Compliance:Providemedicalinputtothe creation,developmentandagreementof promotional material and ensure all material is in line with internal SOPs and meets IFPMA code
• If appropriate to market, Ensure that Pharmacovigilanceactivitiesmeetinternal SOP and local regulations
• Ensure clinical studies are carried out in accordancewithAZSOPsandcGCP.Support Clinical team to select appropriate investigators and sites optimising quality, delivery and commercial benefit

• AlignswiththevaluesandvisionofAZ
• Activelyparticipate/encouragethe development of the AZ culture
• Ensures compliance with AZ code of conduct, Corporate Governance, Audits requirement,guidelines,codes,policiesand procedures
• Ensures that company confidentiality is maintained (i.e. intellectual property, product,strategicandsalaryinformation)
• Disclosespotentialbreachofcodesor conducts

Measures(Quantitative–Qualitative–Attitudinal)

• Display behaviours consistent with theAZvisionandvalues(thosewith line report, their team members demonstrates the same)
• Feedbackfromothers;climatesurvey
• Nonon-complianceissuesraisedwith local and global policies and procedures
• Novalidcomplaintsfromcompetitors against marketing practice
• Nobreachofconfidentiality.All disclosuresareinvestigatedand resolved
• Nocriticalfindinginrelevantinternal or regulatory authority audits

7/ Personaldevelopment

Criticalactions

• Developfunctionalcapabilityintherole
• Communicate,developandrolemodelAZ culture and AZ Values & Behaviours
• Developindividualandteamaccountability
• Identify areas for self-development and discuss developmental needs with line manager using the 70-20-10 principle (experiential learning, coaching/networking/relationship-based learning and class room training)
• Attend&activelyparticipateinlearning programmes, training, projects and meetings (where needed)

Measures(Quantitative–Qualitative–Attitudinal)

• 100%completionoftrainingas required on Medical Academy
• Feedback on congress report/highlightssharedwithcross- functional team as planned – completed feedback templates
• Havingapersonaldevelopmentplan and completes identified development activities as planned Feedback from key stakeholders (optional)

Education, Qualifications, Skills and Experience

Essential

• Amedicaldegreewithspecialization,orappropriate experience, in the required product or disease area
• Medical/Scientificknowledgeintheresponsiblediseasearea
• Interestinalong-termcareerinthepharmaceutical industry
• Excellentpresentationskills
• Anabilityto travel
• FluencyinEnglishisrequired ​

Desirable

• QualifiedDoctor
• MSc/PhDinascientificdiscipline
• UnderstandingofmultipleaspectswithinMedicalAffairs
• Knowledgeofthelatesttechnicalandregulatory developments (essential for Sr MAM)
• Experience of Medical Affairs function within a pharmaceuticalindustry(essentialforSrMAM)
• Experienceinrelationshipandstakeholdermanagement (essential for senior MA)
• Projectmanagementexperience
• Teammanagementexperience(essentialforseniorMAM) ​

Key personal capabilities and attitude

Key Functional Capabilities as defined in MSL Handbook

• Excellent Communication Skills
• Good Planning and Organisational Skills
• Excellent Scientific knowledge
• Ability to develop Strategic Partnerships

Demonstrate AZ Values Consistently

• We follow the science
• We put patients first
• We play to win
• We do the right thing
• We are entrepreneurial

Key Relationships to reach solutions

Internal (to AZ or team)

• SeniorManagementwithinBrandorDiseasearea
• MedicalAffairs Function
• Regulatoryaffairs
• Marketaccess
• Marketing
• R&D team
• ComplianceTeam

External (to AZ)

• ServiceProviders
• Regulatorybodies
• Payor/reimbursementagency
• Otherlocalandregionalstakeholders
• Healthcareprofessionals ​

Date Posted

05-thg 6-2026

Closing Date

30-thg 8-2026

AstraZeneca embraces diversity and equality of opportunity. We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills. We believe that the more inclusive we are, the better our work will be. We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics. We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorization and employment eligibility verification requirements.